Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16830512 | 0.89 | RORC (1.00) | RORC | |
| SCHEMBL16830510 | 0.89 | RORC (1.00) | RORC | |
| SCHEMBL16830503 | 0.89 | RORC (1.00) | RORC | |
| SCHEMBL16830624 | 0.85 | RORC (1.00) | RORC | |
| SCHEMBL16830633 | 0.85 | RORC (1.00) | RORC | |
| SCHEMBL16830477 | 0.85 | RORC (1.00) | RORC | |
| SCHEMBL22776019 | 0.85 | RORC (0.81) | RORC | |
| SCHEMBL16830533 | 0.84 | RORC (1.00) | RORC | |
| SCHEMBL16830644 | 0.84 | RORC (1.00) | RORC | |
| SCHEMBL16830529 | 0.83 | RORC (1.00) | RORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3083624-B1 | TETRAHYDRO-TETRAZOLO[1,5-A]PYRAZINES AS ROR-GAMMA INHIBITORS | MERCK PATENT GMBH (DE) | 2017-12-20 | — | — | EP | claimed |
| US-9688684-B2 | Substituted tetrazolo[1,5-a]pyrazines as ROR-gamma inhibitors | MERCK PATENT GMBH (DE) | 2017-06-27 | — | — | US | claimed |
| US-20160311830-A1 | TETRAHYDRO-TETRAZOLO[1,5-A]PYRAZINES AS ROR-GAMMA INHIBITORS | MERCK PATENT GMBH (DE) | 2016-10-27 | — | — | US | claimed |
| EP-3083624-A1 | TETRAHYDRO-TETRAZOLO[1,5-A]PYRAZINES AS ROR-GAMMA INHIBITORS | Merck Patent GmbH (DE) | 2016-10-26 | — | — | EP | claimed |
| WO-2015090507-A1 | TETRAHYDRO-TETRAZOLO[1,5-A]PYRAZINES AS ROR-GAMMA INHIBITORS | MERCK PATENT GMBH (DE) | 2015-06-25 | — | — | WO | claimed |
| EP-3083624-B1 | TETRAHYDRO-TETRAZOLO[1,5-A]PYRAZINES AS ROR-GAMMA INHIBITORS | MERCK PATENT GMBH (DE) | 2017-12-20 | — | — | EP | disclosed |
| US-9688684-B2 | Substituted tetrazolo[1,5-a]pyrazines as ROR-gamma inhibitors | MERCK PATENT GMBH (DE) | 2017-06-27 | — | — | US | disclosed |
| US-20160311830-A1 | TETRAHYDRO-TETRAZOLO[1,5-A]PYRAZINES AS ROR-GAMMA INHIBITORS | MERCK PATENT GMBH (DE) | 2016-10-27 | — | — | US | disclosed |
| EP-3083624-A1 | TETRAHYDRO-TETRAZOLO[1,5-A]PYRAZINES AS ROR-GAMMA INHIBITORS | Merck Patent GmbH (DE) | 2016-10-26 | — | — | EP | disclosed |
| WO-2015090507-A1 | TETRAHYDRO-TETRAZOLO[1,5-A]PYRAZINES AS ROR-GAMMA INHIBITORS | MERCK PATENT GMBH (DE) | 2015-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160311830-A1 | TETRAHYDRO-TETRAZOLO[1,5-A]PYRAZINES AS ROR-GAMMA INHIBITORS | RORC, RORA, RORB | RORC 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.